Ticagrelor added to methotrexate improves rheumatoid arthritis disease severity.

Authors :: Garshick, Michael S
Rosenthal, Pamela B
Luttrell-Williams, Elliot
Cronstein, Bruce N
Berger, Jeffrey S
Source :: Rheumatology. Nov2021, Vol. 60 Issue 11, p5473-5475. 3p.
Publication Year :: 2021
Abstract: The article discusses a study which considered methotrexate (MTX) as the anchor drug for treatment of rheumatoid arthritis (RA). Topics include one mechanism by which MTX suppresses inflammation in RA, baseline characteristics of the study participants, and effect of one month of ticagrelor therapy added to weekly MTX on RA disease severity.

Full Text Access

Tools